27 – Hyperthermia using nanomagnetic materials

27.1 Introduction
Hyperthermia is a rapidly advancing field within the realm of medical science and
nanotechnology, offering innovative approaches to treat a wide range of diseases, including
cancer. One particularly promising avenue of research involves the use of magnetic
nanoparticles to induce hyperthermia. Hyperthermia, in this context, refers to the controlled
elevation of tissue temperature to therapeutic levels, typically around 40-45°C, for targeted
medical purposes. Magnetic nanoparticles, due to their unique properties and the ability to
generate heat when exposed to an alternating magnetic field, have emerged as a versatile tool
in the quest for more effective and minimally invasive treatments. This module will explore
the principles behind hyperthermia using magnetic nanoparticles, its applications in medicine,
and the potential it holds for revolutionizing the way we combat various diseases.
27.2 Principles of Hyperthermia Using Magnetic Nanoparticles
At the nanoscale, magnetic nanoparticles can exhibit a phenomenon known as the single
domain state. In a single domain state, all the magnetic moments within the nanoparticle align
in the same direction, resulting in a coherent magnetic domain. This alignment occurs when
the size of the nanoparticle is below a critical size called the "single-domain size limit." Below
this limit, the thermal energy at room temperature is insufficient to cause random fluctuations
in the magnetic moments, allowing them to remain aligned. Superparamagnetism is a unique
magnetic behaviour that emerges in magnetic nanoparticles when they are below a critical size
and subjected to thermal energy. Unlike the single domain state, in which the magnetic
moments remain aligned, superparamagnetic nanoparticles have magnetic moments that can
randomly flip orientation due to thermal fluctuations.
The foundation of hyperthermia using magnetic nanoparticles lies in the interaction between
magnetic nanoparticles and an external alternating magnetic field (AMF). These nanoparticles
are typically composed of magnetic materials, such as iron oxide or cobalt ferrite, which exhibit
superparamagnetic behaviour at the nanoscale. When exposed to an AMF, these nanoparticles
rapidly switch their magnetic orientation, generating heat through relaxation losses. The heat
generated can be precisely controlled by adjusting the intensity and frequency of the magnetic
field, allowing for targeted temperature elevation in specific tissues or regions of
interest [1] [2].
27.3 Nanoparticle Synthesis and Material Selection
The first crucial step in preparing magnetic nanoparticles for hyperthermia is the synthesis of
nanoparticles with the desired properties. Various materials, including iron oxide (Fe3O4 and
γ-Fe2O3), cobalt ferrite (CoFe2O4), and nickel ferrite (NiFe2O4), have been employed due to
their superparamagnetic behaviour at the nanoscale [3]. The choice of material depends on
factors like magnetic susceptibility, heating efficiency, and biocompatibility.
Several synthesis techniques exist, such as co-precipitation, sol-gel, thermal decomposition,
and microemulsion methods [4]. These methods allow researchers to precisely control
nanoparticle size, shape, and crystallinity, which are critical for optimizing their heating
capabilities during hyperthermia.

Figure 27.1. TEM image of silica coated maghemite nanoparticle. ©Marko

Petek/commons.wikipedia.org. Shared under: Creative Commons License.

27.4 Surface Functionalization and Targeting

To make magnetic nanoparticles suitable for medical applications, surface functionalization is
essential. The nanoparticles must be engineered to exhibit excellent biocompatibility, stability
in physiological conditions, and the ability to target specific tissues or cells. Coating the
nanoparticles with biocompatible materials like polyethylene glycol, dextran, or silica helps
prevent aggregation and provides a suitable surface for further modification.
To achieve targeted hyperthermia, nanoparticles are often functionalized with ligands or
antibodies specific to receptors overexpressed on the surface of cancer cells or pathogens. This
functionalization allows for precise delivery of nanoparticles to the desired location,
minimizing damage to healthy tissues and enhancing treatment efficacy.
27.5 Magnetic Field Exposure
The cornerstone of magnetic nanoparticle hyperthermia is the exposure to an AMF. The
frequency and intensity of the AMF must be carefully controlled to ensure controlled and
localized heating. Researchers employ different setups, including custom-designed coils and
equipment specifically tailored to the treatment site, to achieve the desired results.
The nanoparticles' superparamagnetic behaviour under the influence of the AMF leads to rapid
magnetic relaxation and, consequently, heat generation. By adjusting the magnetic field
parameters, clinicians can fine-tune the heating process to reach therapeutic temperatures
(typically around 40-45°C) in the target tissue while sparing adjacent healthy tissue.
 27.6 Safety Considerations
Safety is of paramount importance when preparing magnetic nanoparticles for hyperthermia.
While the technique holds great potential, it is essential to minimize potential side effects and
ensure patient well-being. Researchers must address several safety concerns, including the
potential for nanoparticle aggregation, unintended tissue damage, and long-term
biocompatibility.
27.8 Applications in Medicine
i. Cancer Therapy
One of the most prominent applications of magnetic hyperthermia is in cancer treatment.
Magnetic nanoparticles are engineered to selectively target cancer cells by functionalizing
them with specific ligands or antibodies. When exposed to an AMF, these nanoparticles
generate heat, causing localized hyperthermia within the tumor. This elevated temperature
sensitizes the cancer cells to radiation therapy and enhances the effectiveness of
chemotherapy. Moreover, the heat itself can directly damage the tumor cells, leading to their
destruction. Magnetic hyperthermia holds promise in improving the outcomes of various
cancer treatments while minimizing the impact on healthy tissues.
ii. Infectious Disease Treatment
Magnetic hyperthermia is being explored as a potential tool for treating infectious diseases.
Researchers are developing magnetic nanoparticles coated with antimicrobial agents or
antiviral drugs. These nanoparticles can be directed to the site of infection, and when
subjected to an AMF, they induce localized hyperthermia. This controlled heat can kill or
inhibit the growth of pathogens, such as antibiotic-resistant bacteria or viruses, providing an
alternative approach to combat infections and reduce the reliance on systemic antibiotics.
iii. Drug Delivery
Magnetic hyperthermia is also being leveraged for targeted drug delivery. By attaching
therapeutic agents to magnetic nanoparticles and employing an external magnetic field,
researchers can precisely guide these nanoparticles to specific tissues or organs. This
approach enhances drug delivery efficiency, allowing for lower drug doses, reduced side
effects, and increased therapeutic effectiveness. Magnetic nanoparticle-based drug delivery
systems have the potential to revolutionize the treatment of a wide range of diseases.
iv. Nanomedicine and Diagnostics
In addition to therapy, magnetic hyperthermia plays a role in diagnostics and imaging.
Magnetic nanoparticles can serve as contrast agents in magnetic resonance imaging,
enabling clinicians to obtain high-resolution images of tissues and tumors. They can also be
used in theranostics, a field that combines therapy and diagnostics, where magnetic
nanoparticles both deliver therapeutic agents and enable monitoring of treatment response.

27.9 Future Directions

Future research in hyperthermia using magnetic nanoparticles is poised to unlock exciting
possibilities and address current limitations, paving the way for more effective and targeted
therapies. One prominent avenue of research involves nanoparticle engineering and
optimization. Scientists are continually refining the design of magnetic nanoparticles to
enhance their performance in hyperthermia applications. This includes tailoring nanoparticle
size, shape, and surface properties to maximize their heating efficiency while ensuring
biocompatibility and minimizing potential toxicity. Achieving the ideal nanoparticle design is
crucial for improving treatment outcomes [5].
Another critical focus of future research is personalized medicine. By harnessing the potential
of magnetic nanoparticles, researchers aim to develop treatments tailored to individual patients'
unique needs. This approach involves characterizing tumours at the molecular level and
designing hyperthermia protocols that specifically target the genetic and biological
characteristics of each patient's cancer. Personalized hyperthermia promises to increase
treatment effectiveness and reduce adverse effects. Advancements in real-time monitoring and
imaging techniques are also crucial. Researchers are working on developing innovative ways
to track the distribution and accumulation of magnetic nanoparticles in real-time during
treatment. These methods will enable clinicians to ensure precise targeting and assess treatment
efficacy, providing valuable feedback to optimize therapy parameters. Additionally, addressing
questions of safety and long-term toxicity remains a top priority. Comprehensive studies are
needed to assess the potential risks associated with the use of magnetic nanoparticles over
extended periods in the human body. Researchers will investigate how these nanoparticles
interact with biological systems and evaluate their long-term effects to ensure patient safety.
Glossary :
AMF – Alternating Magnetic Field
MRI – Magnetic Resonance Imaging
References
[1] A. B. Salunkhe, V. M. Khot, and S. H. Pawar, Magnetic Hyperthermia with Magnetic
Nanoparticles: A Status Review, Curr. Top. Med. Chem. 14, 572 (2014).
[2] E. A. Perigo, G. Hemery, O. Sandre, D. Ortega, E. Garaio, F. Plazaola, and F. J. Teran,
Fundamentals and Advances in Magnetic Hyperthermia, Appl. Phys. Rev. 2, (2015).
[3] L. Kafrouni and O. Savadogo, Recent Progress on Magnetic Nanoparticles for
Magnetic Hyperthermia, Prog. Biomater. 5, 147 (2016).
[4] A. Rezanezhad, A. Hajalilou, F. Eslami, E. Parvini, E. Abouzari-Lotf, and B.
Aslibeiki, Superparamagnetic Magnetite Nanoparticles for Cancer Cells Treatment
via Magnetic Hyperthermia: Effect of Natural Capping Agent, Particle Size and
Concentration, J. Mater. Sci. Mater. Electron. 32, 24026 (2021).
[5] A. Gholami, S. M. Mousavi, S. A. Hashemi, Y. Ghasemi, W.-H. Chiang, and N.
Parvin, Current Trends in Chemical Modifications of Magnetic Nanoparticles for
Targeted Drug Delivery in Cancer Chemotherapy, Drug Metab. Rev. 52, 205 (2020).